Rhino Federated Computing Company Profile

Background

Rhino Federated Computing, established in November 2020, is dedicated to transforming data collaboration across various industries, with a primary focus on healthcare. The company's mission is to enable organizations to collaborate on data without compromising privacy, security, or data sovereignty. By leveraging federated computing, Rhino aims to unlock the full potential of decentralized data, facilitating advancements in artificial intelligence (AI) and data analytics. Headquartered in Boston, Massachusetts, with a research and development center in Tel Aviv, Rhino has rapidly become a leader in federated computing solutions.

Key Strategic Focus

Rhino's strategic focus centers on developing and deploying federated computing platforms that allow organizations to perform AI and data analytics on decentralized datasets. This approach ensures data privacy and security while enabling collaborative insights. The company's core objectives include:

Data Harmonization: Standardizing diverse datasets to facilitate seamless integration and analysis.

Edge Computing: Processing data locally to minimize latency and enhance security.

Federated Learning: Training AI models across multiple decentralized devices or servers without sharing raw data.

Rhino primarily targets sectors where data sensitivity and regulatory compliance are paramount, such as healthcare, life sciences, and financial services.

Financials and Funding

In May 2025, Rhino Federated Computing announced a $15 million Series A financing round. The round was led by AlleyCorp, with participation from investors including LionBird, Fusion Fund, Arkin Digital Health, Qiming Venture Partners USA, TELUS Global Ventures, Wilson’s Bird Capital, and Keren Maccabi. This funding positions Rhino as the most well-funded and mature federated computing company globally. The capital is intended to accelerate go-to-market strategies across regulated industries, expand the ecosystem of collaborators, broaden support for federated AI use cases, and invest in privacy-preserving, AI-native infrastructure.

Pipeline Development

Rhino's platform has been instrumental in various collaborative projects:

Cancer Center Consortium: The platform facilitated multi-institutional oncology research, enabling breakthroughs in pancreatic cancer detection through privacy-preserving AI.

Biopharma Collaborations: Rhino has supported federated AI initiatives in biopharma, such as the FAITE Biopharma Consortium, accelerating drug development and protein design.

Financial Services: The platform has been utilized by financial institutions to combat fraud through shared models and private data analysis.

These projects demonstrate Rhino's commitment to enabling data collaborations that preserve privacy and security while driving innovation.

Technological Platform and Innovation

Rhino's Federated Computing Platform (FCP) is distinguished by several proprietary technologies and methodologies:

Federated Learning: Allows AI models to be trained across decentralized data sources without transferring raw data, ensuring data privacy and compliance with regulations.

Edge Computing: Processes data locally at the source, reducing latency and enhancing security by minimizing data movement.

Data Harmonization: Utilizes generative AI to standardize diverse datasets into common formats like OMOP and FHIR, facilitating seamless integration and analysis.

Interactive Containers: Enables secure, remote annotation of medical images by experts worldwide, enriching data for AI model training without compromising data security.

These innovations position Rhino as a leader in privacy-preserving AI and data collaboration technologies.

Leadership Team

Rhino's leadership comprises experienced professionals with diverse backgrounds:

Dr. Ittai Dayan, Co-founder & CEO: With a background in leading global collaborations in federated learning, Dr. Dayan drives the company's vision and strategic direction.

Yuval Baror, Co-founder & CTO: An experienced AI entrepreneur, Baror oversees the technological development and innovation of Rhino's platform.

Chris Laws, COO: Manages the company's operations, ensuring efficient execution of strategic initiatives.

Antoni Abella-Vendrell, VP of Product: Leads product development, focusing on user-centric design and functionality.

Adrish Sannyasi, VP of Customer Solutions: Oversees customer engagement and solution delivery, ensuring client satisfaction.

Elke Nelson-Nichols, PhD, VP of Life Sciences: Guides the company's initiatives in the life sciences sector, leveraging extensive industry experience.

Leadership Changes

As of July 2025, there have been no significant changes or appointments within Rhino's leadership team.

Competitor Profile

Market Insights and Dynamics

The federated computing market is experiencing rapid growth, driven by increasing concerns over data privacy and the need for collaborative data analysis across decentralized sources. Industries such as healthcare, life sciences, and financial services are particularly invested in solutions that enable secure data collaboration without compromising privacy.

Competitor Analysis

Rhino operates in a competitive landscape with several key players:

Owkin: Specializes in federated learning for medical research, enabling collaborative AI model training across institutions without sharing patient data.

Secure AI Labs (SAIL): Focuses on secure data collaboration in healthcare, providing platforms that allow institutions to analyze shared datasets without exposing sensitive information.

Intel's OpenFL: An open-source framework for federated learning, facilitating collaborative AI model training across decentralized data sources.

These competitors offer solutions that address similar challenges in data privacy and collaborative analytics, each with unique technological approaches and market focuses.

Strategic Collaborations and Partnerships

Rhino has established significant collaborations to enhance its market position and innovation capacity:

NVIDIA: Partnered to develop a federated computing platform that integrates with NVIDIA's AI infrastructure, expanding the platform's capabilities and reach.

American Heart Association (AHA): Collaborated on the HCM FLIP study, utilizing federated learning to detect hypertrophic cardiomyopathy through electrocardiograms and echocardiograms.

Biopharma Consortia: Engaged with multiple biopharmaceutical companies to facilitate federated AI collaborations, enhancing drug development processes.

These partnerships underscore Rhino's commitment to advancing federated computing across various sectors.

Operational Insights

Rhino's strategic considerations include:

Data Privacy and Security: Emphasizing technologies that ensure data remains within the control of its owners, addressing regulatory and ethical concerns.

Scalability: Designing platforms that can be easily adopted across different industries and scales, from small research institutions to large multinational corporations.

User Autonomy: Providing self-service tools that empower users to conduct experiments and analyses tailored to their specific needs without compromising data security.

These operational strategies differentiate Rhino in the federated computing market.

Strategic Opportunities and Future Directions

Looking ahead, Rhino aims to:

Expand Industry Reach: Extend federated computing solutions to additional regulated sectors such as insurance and government.

Enhance Platform Capabilities: Invest in developing more advanced data harmonization and AI model training features.

Strengthen Global Collaborations: Build and support international consortia to tackle global challenges through collaborative data analysis.

By leveraging its current strengths and strategic partnerships, Rhino is well-positioned to lead the evolution of federated computing across industries.